Immunogen reported $245.76M in Cash and Equivalent for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acceleron Pharma XLRN:US $ 336.46M 0.26M
Agios Pharmaceuticals AGIO:US $ 400.22M 568.9M
Amgen AMGN:US $ 11969M 5339M
Arena Pharmaceuticals ARNA:US $ 386.65M 127.52M
Astellas Pharma 4503:JP Y 318295M 16375M
AstraZeneca AZN:LN 7067M 8500M
Bluebird Bio BLUE:US $ 402.46M 48.99M
Bristol Myers Squibb BMY:US $ 13540M 2516M
Cerulean Pharma CERU:US $ 45.57M 36.46M
Dicerna Pharmaceuticals DRNA:US $ 165.76M 55.45M
Eli Lilly And LLY:US $ 3788.2M 568.2M
Emergent Biosolutions EBS:US $ 403.8M 43.7M
Exelixis EXEL:US $ 567.33M 74.86M
Halozyme Therapeutics HALO:US $ 491.68M 44.72M
Heron Therapeutics HRTX:US $ 159.57M 31.6M
Immunogen IMGN:US $ 245.76M 6.22M
Intrexon XON:US $ 41.73M 5.32M
Karyopharm Therapeutics KPTI:US $ 137.4M 3.91M
Macrogenics MGNX:US $ 190.53M 1.56M
Nektar Therapeutics NKTR:US $ 54.02M 98.33M
Novartis NVS:US $ 7211M 2094M
Regeneron Pharmaceuticals REGN:US $ 3432.4M 1360.2M
Seattle Genetics SGEN:US $ 685.17M 271.74M